Indication
Influenza B
3 clinical trials
8 products
Clinical trial
An Exploratory Study To Establish The Dose, Safety, And Pathogenicity Of A New Influenza B Challenge Strain In Healthy Participants 18 To 55 Years Of AgeStatus: Recruiting, Estimated PCD: 2024-02-02
Product
Influenza B/Connecticut/1/21Product
GrippolClinical trial
Multicenter, Double-blind, Randomized, Parallel Group Study to Evaluate the Immunogenicity, Reactogenicity and Safety of the Grippol® Quadrivalent Vaccine in Children Aged 6 Months to 5 Years (Inclusive)Status: Completed, Estimated PCD: 2023-06-15
Clinical trial
An Phase I, Open-label, Multi-center, Parallel, Single Oral Dose Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of ADC189 in Subjects With Hepatic Impairment (Child-Pugh A and B) Compared With Subjects With Normal Hepatic FunctionStatus: Recruiting, Estimated PCD: 2024-09-30
Product
ADC189